Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature
Open Access
- 23 January 2015
- journal article
- review article
- Published by Springer Nature in SpringerPlus
- Vol. 4 (1) , 29
Abstract
Dapsone is a commonly used second line drug for prophylaxis of pneumocystis jirovecii pneumonia (PJP) in immunocompromised patients. Oxidant hemolysis, caused by dapsone’s metabolite hydroxylamine, is a common side effect, and screening for glucose-6-phosphate dehydrogenase (G6PD) deficiency is recommended before the drug is started in order to prevent potential hemolytic reactions. We report a case of dapsone induced hemolytic anemia in a patient with ANCA associated glomerulonephritis and normal G6PD level. Her anemia improved after cessation of therapy with dapsone. We review the literature of dapsone induced hemolysis in patients who have normal G6PD level and discuss potential pathways leading to hemolytic anemia and its implications for clinical practice.Keywords
This publication has 12 references indexed in Scilit:
- G6PD deficiency: a classic example of pharmacogenetics with on‐going clinical implicationsBritish Journal of Haematology, 2013
- EULAR recommendations for the management of primary small and medium vessel vasculitisAnnals of the Rheumatic Diseases, 2009
- Dapsone-induced Hemolytic Anemia in Lung Allograft RecipientsThe Journal of Heart and Lung Transplantation, 2008
- G6PD deficiency: the genotype-phenotype associationBlood Reviews, 2007
- Complications Related to Dapsone Use for Pneumocystis Jirovecii Pneumonia Prophylaxis in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2005
- Use of Dapsone in the Prevention and Treatment ofPneumocystis cariniiPneumonia: A ReviewClinical Infectious Diseases, 1998
- A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosisArthritis & Rheumatism, 1997
- Pneumocystis carinii Pneumonia: A Major Complication of Immunosuppressive Therapy in Patients with Wegener's GranulomatosisAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Membrane cross bonding in red cells in favic crisis: a missing link in the mechanism of extravascular haemolysisBritish Journal of Haematology, 1985
- The Mechanism of Glutathione Destruction and Protection in Drug-Sensitive and Non-Sensitive Erythrocytes. In Vitro StudiesJournal of Clinical Investigation, 1957